United States · Platforms & data · Finviz

Kura Oncology to Report Third Quarter Financial Results on November 10

Published by Finviz · United States 9 h ago

Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced it will report its third quarter 2026…

Read the full article on Finviz Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finviz.com)

Also worth reading

Seeking Alpha

Revvity rises on full-year guidance boost

The Motley Fool

Warren Buffett Has 1 Simple Rule for Investing During Bear Markets. History Says He's Right.

CNBC

Stock market after midterm elections: What S&P 500 history shows

Benzinga

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

MarketWatch

5 questions to ask if your boss offers you a buyout, as Microsoft did with 60,000 employees

Investing.com